losartan has been researched along with 3,4-dihydroxyphenylpropionic acid in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Alajarín, R; Alvarez-Builla, J; Díez-Marqués, ML; García, G; Griera, M; Rodríguez-Puyol, D; Rodríguez-Puyol, M; Sánchez-Alonso, P; Serrano, I; Vaquero, JJ | 2 |
| Alajarín, R; Alonso-Montes, C; Alvarez-Builla, J; Cannata-Andía, JB; Carrillo-López, N; Fernández-Villabrille, S; García-Navazo, G; Gutiérrez-Calabres, E; Martínez-Arias, L; Naves-Díaz, M; Panizo, S; Rodríguez-Puyol, D; Ruíz-Torres, MP; Vaquero-López, JJ | 1 |
3 other study(ies) available for losartan and 3,4-dihydroxyphenylpropionic acid
| Article | Year |
|---|---|
Losartan-antioxidant hybrids: novel molecules for the prevention of hypertension-induced cardiovascular damage.
Topics: Alcohols; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antioxidants; Blood Pressure; Cardiovascular Diseases; Cells, Cultured; Collagen Type I; Esters; Fibronectins; Humans; Hypertension; Losartan; Male; Oxidative Stress; Rats; Rats, Wistar | 2009 |
New losartan-hydrocaffeic acid hybrids as antihypertensive-antioxidant dual drugs: Ester, amide and amine linkers.
Topics: Amides; Amines; Angiotensin II; Animals; Antihypertensive Agents; Antioxidants; Aorta, Thoracic; Caffeic Acids; Cells, Cultured; Esters; Hypertension; Losartan; Male; Molecular Structure; Muscle, Smooth, Vascular; Rats; Rats, Wistar; Structure-Activity Relationship; Vasoconstrictor Agents | 2012 |
Effects of a Losartan-Antioxidant Hybrid (GGN1231) on Vascular and Cardiac Health in an Experimental Model of Chronic Renal Failure.
Topics: Animals; Antioxidants; Fibrosis; Kidney; Kidney Failure, Chronic; Losartan; Male; Models, Theoretical; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2023 |